Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial - Lopez-Neyra, Alejandro; Suarez, Lucretia; Munoz, Marta; de Blas, Ana; de Valbuena, Marta Ruiz; Garriga, Maria; Calvo, Joaquim; Ribes, Carmen; Moreno, Rosa Giron; Maiz, Luis; Gonzalez, David; Bousono, Carlos; et al. (Prostaglandins Leukotrienes and Essential Fatty Acids, 2020)